Myriad Genetics | MYGN - Selling And Administration Expenses


Myriad Genetics reported $129M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Bruker USD 242.5M 11.1M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 256M 59M Sep/2025
J&J USD 6.75B 831M Dec/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Quest Diagnostics USD 501M 15M Sep/2025
Quidel USD 186.9M 16.8M Sep/2025
Repligen USD 73.66M 2.43M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Standard Biotools USD 26.6M 1.5M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Veracyte USD 51.73M 5.91M Sep/2025
Waters USD 214.23M 12.97M Sep/2025